Letter to Editor
Response to Infliximab Biosimilar in a Case of Reactive Arthritis: Our Experience
Published: December 1, 2019 | DOI: https://doi.org/10.7860/JCDR/2019/42695.13357
Amruta Deepak Morey, Bhushan Sevakram Madke, Adarsh Lata Singh3, Sudhir Singh, Sandeep Kulkarni
|